Thurston, Springer, Miller, Herd & Titak, Inc. Sanofi Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $283 Million
- Q2 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Sanofi stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 173 shares of SNY stock, worth $9,598. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173Holding current value
$9,598% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNY
# of Institutions
795Shares Held
252MCall Options Held
2.6MPut Options Held
1.64M-
Dodge & Cox San Francisco, CA77.1MShares$4.28 Billion2.36% of portfolio
-
Morgan Stanley New York, NY14.7MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.6MShares$754 Million0.29% of portfolio
-
Bank Of America Corp Charlotte, NC11.2MShares$622 Million0.05% of portfolio
-
Invesco Ltd. Atlanta, GA10.5MShares$583 Million0.11% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $139B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...